TotalMarketCap

Kiniksa Pharmaceuticals International

KNSANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$6.947 B

$88.42 -8.01%

Close of 6 Nov 2026

As of 6 Nov 2026, Kiniksa Pharmaceuticals International (KNSA) has a market capitalization of $6.95B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$677.6M

#1737 by revenue

Earnings

$59.0M

#1495 by earnings

Shares outstanding

83,713,015

Latest filing cover page

P/E ratio

117.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #42Praxis Precision MedicinesPRAX$7.34B
  2. #43Rhythm PharmaceuticalsRYTM$7.21B
  3. #44Kiniksa Pharmaceuticals InternationalKNSA$6.95B
  4. #45Axsome TherapeuticsAXSM$6.80B
  5. #46Amneal PharmaceuticalsAMRX$6.78B

What if Kiniksa Pharmaceuticals International were worth as much as…

Open the what-if tool →

Gold $28.2T

$359,377.13

Per share 4,064× higher

Bitcoin $1.53T

$19,445.27

Per share 220× higher

Apple $5.02T

$63,837.01

Per share 722× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Kiniksa Pharmaceuticals International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.